NFA
TENX icon

Nationwide Fund Advisors’s Tenax Therapeutics TENX Stock Holding History

Nationwide Fund Advisors’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2
Closed -$137K – 3216
2016
Q4 		$137K Hold
2
– – ﹤0.01% 2766
2016
Q3 		$161K Hold
2
– – ﹤0.01% 2727
2016
Q2 		$154K Hold
2
– – ﹤0.01% 2734
2016
Q1 		$123K Hold
2
– – ﹤0.01% 2737
2015
Q4 		$197K Buy
2
+1
+100% +$104K ﹤0.01% 2562
2015
Q3 		$76K Buy
+1
New +$114K ﹤0.01% 2962

Other funds holding TENX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Nationwide Fund Advisors's TENX Position: Q1 2017 in Review

Nationwide Fund Advisors sold out of Tenax Therapeutics (TENX) in Q1 2017, closing a stake of 2 shares — an estimated $137K sold.

Nationwide Fund Advisors first reported a position in TENX in Q3 2015 and held it in 6 quarters. The position peaked at $197K in Q4 2015. 11 funds tracked by Wall St. Rank hold TENX as of Q1 2017.

  • Nationwide Fund Advisors reported no remaining Tenax Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 2 Tenax Therapeutics shares in Q1 2017, an estimated $137K.
  • Nationwide Fund Advisors first reported a position in Tenax Therapeutics in Q3 2015 and held it in 6 quarters.
  • Nationwide Fund Advisors's Tenax Therapeutics position peaked at $197K in Q4 2015.
  • 11 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2017.

Based on Nationwide Fund Advisors's 13F filing for Q1 2017, filed 21 Apr 2017.